{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:23:05Z","timestamp":1783027385784,"version":"3.54.6"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007688","name":"American University of Beirut","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ajo.2025.11.031","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T15:16:03Z","timestamp":1763910963000},"page":"416-426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Retrospective Analysis of Pediatric Optic Pathway Gliomas: Impact of NF1 Status on Visual and Structural Outcomes"],"prefix":"10.1016","volume":"282","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6299-9030","authenticated-orcid":false,"given":"Sally","family":"Al Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reine","family":"Zankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Elbejjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa Bou","family":"Ghannam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl_2","key":"10.1016\/j.ajo.2025.11.031_bib0001","first-page":"ii1","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010","volume":"15","author":"Ostrom","year":"2013","journal-title":"Neuro-Oncol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.031_bib0002","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ana.21107","article-title":"Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations","volume":"61","author":"Listernick","year":"2007","journal-title":"Ann Neurol: Off J Am Neurol Assoc Child Neurol Soc"},{"issue":"suppl_4","key":"10.1016\/j.ajo.2025.11.031_bib0003","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/nou223","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007\u20132011","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro-Oncol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.031_bib0004","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ajmg.a.20650","article-title":"Outcomes of systematic screening for optic pathway tumors in children with neurofibromatosis type 1","volume":"127","author":"Blazo","year":"2004","journal-title":"Am J Med Genet A"},{"issue":"16","key":"10.1016\/j.ajo.2025.11.031_bib0005","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1038\/onc.2013.148","article-title":"The molecular and cell biology of pediatric low-grade gliomas","volume":"33","author":"Chen","year":"2014","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.031_bib0006","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/08830738030180070401","article-title":"Optic pathway gliomas in children with and without neurofibromatosis 1","volume":"18","author":"Czyzyk","year":"2003","journal-title":"J Child Neurol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.031_bib0007","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2217\/cns.12.47","article-title":"Optic pathway gliomas: a review","volume":"2","author":"Fried","year":"2013","journal-title":"CNS Oncol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.031_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8","article-title":"Epidemiology of neurofibromatosis type 1","volume":"89","author":"Friedman","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ajo.2025.11.031_bib0009","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.031_bib0010","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/pbc.22748","article-title":"Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1","volume":"55","author":"Campagna","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.031_bib0011","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/neuonc\/nos076","article-title":"Visual outcomes in children with neurofibromatosis type 1\u2013associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis","volume":"14","author":"Fisher","year":"2012","journal-title":"Neuro-Oncol"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.031_bib0012","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0161-6420(84)34217-8","article-title":"Von recklinghausen neurofibromatosis: II. Incidence of optic gliomata","volume":"91","author":"Lewis","year":"1984","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.031_bib0013","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ajo.2003.09.055","article-title":"Optic radiation involvement in optic pathway gliomas in neurofibromatosis","volume":"137","author":"Liu","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.031_bib0014","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3171\/jns.1997.86.5.0747","article-title":"Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas","volume":"86","author":"Packer","year":"1997","journal-title":"J Neurosurg"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.031_bib0015","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0887-8994(02)00628-8","article-title":"Long-term outcome in children with gliomas of the anterior visual pathway","volume":"28","author":"Tow","year":"2003","journal-title":"Pediatr Neurol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.031_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212107","article-title":"Long-term visual acuity in patients with optic pathway glioma treated during childhood with up-front BB-SFOP chemotherapy\u2014analysis of a french pediatric historical cohort","volume":"14","author":"Rakotonjanahary","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.031_bib0017","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/WNO.0b013e31822aef82","article-title":"Optic pathway gliomas","volume":"31","author":"Avery","year":"2011","journal-title":"J Neuro-Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.031_bib0018","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11060-013-1300-6","article-title":"Vision specific quality of life in children with optic pathway gliomas","volume":"116","author":"Avery","year":"2014","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.031_bib0019","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/jamaophthalmol.2013.5819","article-title":"Marked recovery of vision in children with optic pathway gliomas treated with bevacizumab","volume":"132","author":"Avery","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.031_bib0020","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S1470-2045(19)30277-3","article-title":"Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial","volume":"20","author":"Fangusaro","year":"2019","journal-title":"Lancet Oncol"},{"issue":"24","key":"10.1016\/j.ajo.2025.11.031_bib0021","doi-asserted-by":"crossref","first-page":"7303","DOI":"10.1158\/1078-0432.CCR-19-2177","article-title":"Efficacy and safety of dabrafenib in pediatric patients with BRAF V600 mutation\u2013positive relapsed or refractory low-grade Glioma: results from a phase I\/IIa study","volume":"25","author":"Hargrave","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.031_bib0022","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/nop\/npz076","article-title":"Efficacy and safety of bevacizumab in progressive pediatric low-grade glioma: a systematic review and meta-analysis of outcome rates","volume":"7","author":"Lu","year":"2020","journal-title":"Neuro-Oncol Pract"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.031_bib0023","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/cam4.1799","article-title":"Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma","volume":"8","author":"Zhukova","year":"2019","journal-title":"Cancer Med"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.031_bib0024","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ajo.2010.08.046","article-title":"Retinal nerve fiber layer thickness in children with optic pathway gliomas","volume":"151","author":"Avery","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"13","key":"10.1016\/j.ajo.2025.11.031_bib0025","doi-asserted-by":"crossref","first-page":"8112","DOI":"10.1167\/iovs.13-13093","article-title":"Optical coherence tomography in the diagnosis of optic pathway gliomas","volume":"54","author":"Parrozzani","year":"2013","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"21_supplement_1","key":"10.1016\/j.ajo.2025.11.031_bib0026","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1212\/01.wnl.0000435745.95155.b8","article-title":"Functional outcome measures for NF1-associated optic pathway glioma clinical trials","volume":"81","author":"Fisher","year":"2013","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.031_bib0027","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/ICU.0000000000000587","article-title":"Current treatment of optic nerve gliomas","volume":"30","author":"Farazdaghi","year":"2019","journal-title":"Curr Opin Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.031_bib0028","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.ajo.2015.07.036","article-title":"Longitudinal change of circumpapillary retinal nerve Fiber layer thickness in children with optic pathway gliomas","volume":"160","author":"Avery","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.031_bib0029","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1080\/26895293.2022.2046180","article-title":"Optic nerve gliomas in adults: a SEER-based study","volume":"15","author":"Lin","year":"2022","journal-title":"All Life"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.031_bib0030","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/humu.22392","article-title":"NF 1 molecular characterization and neurofibromatosis type I genotype\u2013phenotype correlation: the F Rench experience","volume":"34","author":"Sabbagh","year":"2013","journal-title":"Hum Mutat"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.031_bib0031","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/pbc.22198","article-title":"Natural history and outcome of optic pathway gliomas in children","volume":"53","author":"Nicolin","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.031_bib0032","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2174\/156652409788488801","article-title":"Developmental abnormalities and cancer predisposition in neurofibromatosis type 1","volume":"9","author":"Larizza","year":"2009","journal-title":"Curr Mol Med"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.031_bib0033","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1212\/01.wnl.0000257095.33125.48","article-title":"Moyamoya following cranial irradiation for primary brain tumors in children","volume":"68","author":"Ullrich","year":"2007","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.031_bib0034","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/pbc.24726","article-title":"Visual acuity of children treated with chemotherapy for optic pathway gliomas","volume":"61","author":"Kalin-Hajdu","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.031_bib0035","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1215\/15228517-2007-031","article-title":"Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program","volume":"9","author":"Via","year":"2007","journal-title":"Neuro-Oncol"},{"issue":"26","key":"10.1016\/j.ajo.2025.11.031_bib0036","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa1605943","article-title":"Activity of selumetinib in neurofibromatosis type 1\u2013related plexiform neurofibromas","volume":"375","author":"Dombi","year":"2016","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.ajo.2025.11.031_bib0037","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1158\/0008-5472.CAN-12-0334","article-title":"Sensitivity of glioblastomas to clinically available MEK inhibitors is defined by neurofibromin 1 deficiency","volume":"72","author":"See","year":"2012","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.031_bib0038","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jaapos.2010.08.014","article-title":"Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas","volume":"14","author":"Chang","year":"2010","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.031_bib0039","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ophtha.2003.06.008","article-title":"Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients","volume":"111","author":"Thiagalingam","year":"2004","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.031_bib0040","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41433-022-02096-1","article-title":"Visual outcomes and predictors in optic pathway glioma: a single centre study","volume":"37","author":"Bowman","year":"2023","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.031_bib0041","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11060-016-2163-4","article-title":"Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1","volume":"129","author":"Wan","year":"2016","journal-title":"J Neuro-Oncol"},{"key":"10.1016\/j.ajo.2025.11.031_bib0042","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pediatrneurol.2017.06.019","article-title":"Clinical presentation and outcome of patients with optic pathway glioma","volume":"75","author":"Robert-Boire","year":"2017","journal-title":"Pediatr Neurol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425006300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425006300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:02:20Z","timestamp":1783026140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939425006300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":42,"alternative-id":["S0002939425006300"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2025.11.031","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retrospective Analysis of Pediatric Optic Pathway Gliomas: Impact of NF1 Status on Visual and Structural Outcomes","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2025.11.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}